Arkolith/Insider Trading/MURA/Form 4

Keson-Brookes Maiken

See RemarksMural Oncology plc (MURA) · full profile →Form 4 · filed Jul 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 18, 2024Sell(S)2K$3.41$7K44K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-084569) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML